Outcomes of acute myeloid leukemia with KMT2A (MLL) rearrangement: a multicenter study of TROPHY group.

Blood Cancer J · 2025 · PMC12048516 · PMID 40316511

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendP = 0.055so close (0.05 < p ≤ 0.1)

Patients harboring KMT2A::MLLT1 , however, showed a trend towards worse clinical outcomes compared to their counterparts (3-year OS: 32.8% vs. 60.4%, P = 0.055; CIR: 58.8% vs. 31.4%, P = 0.087) (Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.